Dermatology · Long Beach, NY
NPI
1821037664
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
604 E Park Ave
Long Beach, NY, 11561
Phone (516) 432-0011
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
23,119 services
Medicare patients, 2024
2,108
Average age 73
Drug cost, 2024
$729K
3,553 prescriptions
Company payments, 2025
$6,608
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by K. Andrew Cerveny Jr. was code 17003 (destruction skin lesion), 7,559 times for 1,081 patients. In total K. Andrew Cerveny Jr. billed 23,119 services in 55 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 7,559 | 1,081 | $6.06 | $46K |
| 99213 Office E&M - Established | Office | 3,237 | 1,641 | $73.98 | $239K |
| 17110 Destruction Skin Lesion | Office | 2,804 | 1,565 | $83.87 | $235K |
| 17000 Destruction Skin Lesion | Office | 1,771 | 1,197 | $31.65 | $56K |
| 11102 Skin Biopsy | Office | 1,507 | 1,131 | $49.01 | $74K |
| 17004 Destruction Skin Lesion | Office | 927 | 616 | $143.44 | $133K |
| 99214 Office E&M - Established | Office | 668 | 525 | $99.89 | $67K |
| 11302 Removal or Shaving of Skin Growth | Office | 556 | 324 | $97.93 | $54K |
| 10040 Removal or Shaving of Skin Growth | Office | 373 | 330 | $87.14 | $33K |
| 99203 Office E&M - New | Office | 246 | 246 | $84.53 | $21K |
| 11103 Skin Biopsy | Office | 214 | 165 | $45.87 | $9,815 |
| 69100 Other Organ Systems | Office | 213 | 161 | $44.60 | $9,499 |
| 96910 Skin | Office | 197 | 25 | $106.12 | $21K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 196 | 154 | $0.71 | $139 |
| 11900 Skin | Office | 154 | 131 | $31.52 | $4,853 |
By year: 2022 $1.2M for 18,954 services; 2023 $1.2M for 21,414 services; 2024 $1.3M for 23,119 services.
Medicare prescription drug claims, 2024
In 2024, the drug K. Andrew Cerveny Jr. prescribed most often to Medicare patients was Ketoconazole, with 675 prescriptions and refills. In total K. Andrew Cerveny Jr. wrote 3,553 Medicare prescriptions that cost $729K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 675 | 702 | 193 | $21K |
| Triamcinolone Acetonide Generic | 405 | 427 | 291 | $4,604 |
| Clindamycin Phosphate Generic | 250 | 272 | 89 | $20K |
| Mupirocin Generic | 250 | 250 | 107 | $3,130 |
| Metronidazole Generic | 233 | 248 | 97 | $17K |
| Betamethasone Dipropionate Generic | 229 | 242 | 152 | $10K |
| Fluocinonide Generic | 224 | 231 | 141 | $11K |
| Hydrocortisone Generic | 194 | 194 | 137 | $1,075 |
| Econazole Nitrate Generic | 97 | 98 | 41 | $4,399 |
| Clobetasol Propionate Generic | 79 | 87 | 47 | $5,029 |
| Minocycline Hcl Generic | 75 | 79 | 58 | $1,185 |
| Ammonium Lactate Generic | 73 | 75 | 28 | $2,913 |
| Nystatin Generic | 70 | 70 | 30 | $1,431 |
| Tretinoin Generic | 69 | 80 | 29 | $6,195 |
| Ciclopirox Generic | 54 | 56 | 31 | $2,425 |
Brand drugs: 246 claims; generic drugs: 3,307 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid K. Andrew Cerveny Jr. $6,608 ($6,608 in general payments such as food, travel and fees) from 25 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $1,514.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 41 | $1,514 |
| Abbvie Inc. ABBV | 31 | $598 |
| LEO Pharma Inc. | 24 | $539 |
| Galderma Laboratories, L.P. GALD.SW | 23 | $403 |
| Janssen Biotech, Inc. JNJ | 14 | $334 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 32 | $320 |
| Lilly USA, LLC LLY | 15 | $308 |
| Incyte Corporation INCY | 13 | $302 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $283 |
| Organon LLC OGN | 12 | $251 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.